Chapters

Transcript

Video

What have we learned about resistance to molecular targets, and how have serial NGS assessments with progressive biopsies helped us understand drug resistance and sequential therapies?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Samuel Klempner, MD

Samuel Klempner, MD

Director of Precision Medicine
The Angeles Clinic and Research Institute
Cedars-Sinai Medical Center
Los Angeles, CA